2-Bromo-5-methoxypyridine | CAS:105170-27-2

We serve 2-Bromo-5-methoxypyridine CAS:105170-27-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-5-methoxypyridine

Chemical Name:2-Bromo-5-methoxypyridine
CAS.NO:105170-27-2
Synonyms:2-bromo-5-methoxypyridine;
Molecular Formula:C6H6BrNO
Molecular Weight:188.02200
 
Physical and Chemical Properties:
Density:1.53;
Boiling point:240.8oC;
Flash point:99.4oC;
Index of Refraction:1.542;
 
Specification:
Appearance:Colourless to light yellow liquid
Purity(HPLC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Bromo-5-methoxypyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-5-methoxypyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-5-methoxypyridine Use and application,2-Bromo-5-methoxypyridine technical grade,usp/ep/jp grade.


Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.(S)-1-Boc-3-hydroxypiperidine manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.4-(2-methylpropyl)oxane-2,6-dione supplier Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.2-(3,4-dimethylphenyl)-5-methyl-4H-pyrazol-3-one vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.